Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  News  >  Indexes & Markets

News : Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 

U.S. Stock Futures Rise Ahead of Stimulus Talks Deadline

10/20/2020 | 09:17am EST

By Anna Hirtenstein

U.S. stock futures ticked up ahead of House Speaker Nancy Pelosi's Tuesday deadline for Congress to reach an agreement on a spending package to support American households and businesses through the pandemic.

Securities tied to the S&P 500 rose 0.4%, indicating that U.S. stocks may gain after the opening bell. The broad-market index fell 1.6% Monday as investors grew concerned that lawmakers weren't making progress on a deal.

Mrs. Pelosi has indicated that the White House needs to reach a deal with Democrats by the end of Tuesday if the government wants to pass the next coronavirus-relief bill before Election Day. The California Democrat and Treasury Secretary Steven Mnuchin edged closer on some policy differences holding up a sweeping coronavirus relief package, but disputes remained. Both sides said they are continuing to work on the matter.

"There has to be some form of a deal: the most likely outcome is that they'll have to do something. Given what's happening with Covid, the economy needs some support and markets need some form of guidance," said Peter Dixon, an economist at Commerzbank. But "we are really running out of time," he cautioned.

Markets have swung in recent weeks on every twist in the talks. If passed, the stimulus package could drive a further rally in stocks.

In bond markets, the yield on the benchmark 10-year U.S. Treasury note ticked up to 0.788%, from 0.760% on Monday.

Investors are also continuing to assess the elevated number of new coronavirus infections in the U.S. and Europe in recent weeks. Restrictions in some countries including the U.K. and France have been tightened, though most governments have avoided halting business activity completely, shielding the economy from the worst of the fallout.

"On the virus front, headlines are getting worse, but our base case is still that there won't be another full lockdown," said Fahad Kamal, chief investment officer at Kleinwort Hambros. "There's still a big difference between localized, targeted lockdowns and the shutdowns we had in March and April."

Overseas, the pan-continental Stoxx Europe 600 edged down 0.1%. In European equities, Logitech rallied 15% after it posted a massive jump in sales from a spike in demand for computer equipment as more people worked from home. UBS shares rose 4% after it said its net profit doubled from a surge in trading and it is setting aside billions for dividends and share buybacks.

China's Shanghai Composite Index advanced 0.5% by the close of trading, while Japan's Nikkei 225 retreated 0.4%.

Permits for new construction in the U.S. were at 1.553 million in September, rising moderately compared with the previous month. The figures were slightly above economists' expectations, reflecting a continued recovery in the bedrock industry.

Shares of consumer retail company Procter & Gamble rose 1.5% premarket after it reported a surge in sales and revised up its expectations for growth and plans for stock buybacks next year. Technology firms Netflix and Snap, the developer of the SnapChat app, are expected to release earnings after the market closes.

Netflix in particular will be closely watched for indications of the extent to which tech companies are continuing to benefit from people spending more time at home during the pandemic, according to Mr. Kamal. The stock has been among the best performers this year, and has climbed over 60% so far.

Strong results from Netflix will "be the latest bit of validation on whether the enormous valuations that we're paying, do they make sense?" Mr. Kamal said. "It will be reflective of the stay-at-home trade in the wider sense, the trade that's been by far the winner over the course of this year."

Ahead of the opening bell in New York, shares of drugmaker Moderna rose 2.6% after it said its coronavirus vaccine could be authorized in December if it gets positive results next month from its clinical trial. IBM shares dropped 3.7% after it reported results after hours, which included a decline in revenue and no guidance on its outlook.

Write to Anna Hirtenstein at anna.hirtenstein@wsj.com

(END) Dow Jones Newswires

10-20-20 0916ET

Stocks mentioned in the article
ChangeLast1st jan.
DJ INDUSTRIAL 0.13% 29910.37 Delayed Quote.4.81%
LOGITECH INTERNATIONAL S.A. 2.53% 80.36 Delayed Quote.70.98%
MODERNA, INC. 16.35% 127.03 Delayed Quote.549.44%
NASDAQ 100 0.87% 12258.211779 Delayed Quote.40.37%
NASDAQ COMP. 0.92% 12205.846315 Delayed Quote.36.03%
NETFLIX, INC. 1.31% 491.36 Delayed Quote.51.86%
NIKKEI 225 -0.79% 26433.62 Real-time Quote.12.63%
S&P 500 0.24% 3638.35 Delayed Quote.12.62%
S&P/CITIC 300 INDEX -0.48% 4306.96 Delayed Quote.21.84%
S&P/CITIC 50 INDEX -0.86% 4330.11 Delayed Quote.16.87%
SNAP INC. 1.03% 46.03 Delayed Quote.181.87%
STOXX EUROPE 600 -0.04% 392.99 Delayed Quote.-5.44%
UBS GROUP AG -0.87% 13.04 Delayed Quote.7.65%
Latest news "Markets"
09:35aWALL STREET STOCK EXCHANGE : S&P 500, Dow slip at open, still set for stellar November
09:34aWALL STREET STOCK EXCHANGE : S&P 500, Dow slip at open, still set for stellar November
09:26aWALL STREET STOCK EXCHANGE : Gold spirals lower on vaccine-led economic recovery bets
09:26aDow on Track to Finish Best Month in Over Three Decades
05:49aDow on Track to Finish Best Month in 33 Years
04:30aEUROPE : European shares muted at end of stellar month; eyes on Brexit
04:27aEuropean shares muted at end of stellar month; eyes on Brexit
04:15aFTSE 100 set for best month ever on vaccine, recovery hopes
04:14aFTSE 100 set for best month ever on vaccine, recovery hopes
03:44aNasdaq 100 e-mini futures pare losses in early european trade, last flat, s&p 500 e-minis down 0.4%
Latest news "Markets"